Quantcast
Last updated on April 24, 2014 at 5:50 EDT

Latest Cervarix Stories

2009-11-03 10:00:00

NEW YORK, Nov. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. GlaxoSmithKline plc: PharmaVitae Profile http://www.reportlinker.com/p0157541/GlaxoSmithKline-plc-PharmaVitae-Profile.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Introduction This analysis examines the historical and forecast performance for GSK in the prescription pharmaceutical sector. The profile encompasses global company...

6378b1e5c41725b3bc9e68bc923b137d1
2009-10-22 07:40:00

The U.S. Advisory Committee on Immunization Practices (ACIP) delivered a nearly unanimous vote on Wednesday against "permissive" use of Merck & Co.'s Gardasil for boys and men, deciding instead to advise doctors that they are free to use the vaccine if they choose. The Gardasil vaccine provides protection against the human papillomavirus (HPV), which can cause genital warts and a number of cancers. The U.S. Centers for Disease Control and Prevention (CDC) currently recommends Gardasil...

2009-10-21 11:40:00

PHILADELPHIA, Oct. 21 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18. The ACIP specifically recommended...

2009-10-16 10:25:00

PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25). "The approval of CERVARIX will bring an important new...

2009-10-15 14:20:10

Contrary to concerns that the human papillomavirus vaccine might promote promiscuity, a national survey of girls and young women found that the majority of respondents did not believe the HPV vaccine protected them against other sexually transmitted infections. The study, conducted by University of Illinois at Chicago and University of Chicago researchers, appears online and in the November issue of the Journal of Adolescent Health. The findings are reassuring in that girls and young women...

2009-10-09 13:40:19

Cervical cancer prevention efforts should prioritize vaccinating pre-adolescent girls and continued cervical cancer screening Persistent infection with high-risk types of human papillomavirus (HPV), a sexually transmitted virus, is known to be a cause of cervical cancer. Current guidelines prioritize HPV vaccination of pre-adolescent girls, which has been shown to be cost-effective in previous studies, but the value of vaccinating boys in the United States has been unclear. In a new study,...

c7298a597edbc91e0adeae2a8bd841c21
2009-09-29 13:25:29

Health authorities are working alongside British drug giant GlaxoSmithKline in an effort to investigate the death of a schoolgirl following a cervical cancer vaccination, AFP reported. Following an adverse reaction to the Cervarix vaccine, the 14-year-old girl died on Monday after participating in a national vaccination program that is being carried out in England to protect women against the disease. Health authorities have since isolated the batch of vaccine used in the school. The Cervarix...

2009-09-29 10:57:24

A 14-year-old girl British girl died and several others were hospitalized after being vaccinated against the human papilloma virus, officials said. Natalie Morton died Monday after being vaccinated with Cervarix at her school in Coventry, The Times of London reported Tuesday. Several classmates were hospitalized the same day with side effects from Cervarix, a vaccine that protects against cervical cancer, The Times reported. Morton's is the first death in a national campaign that has...

34365a69a790bfa30540273ccc76cc661
2009-09-18 12:46:41

A federal report released Thursday showed that one in three teenage girls have gotten a cervical cancer vaccine, but vaccination rates vary dramatically between states, The Associated Press reported. It showed that over half of girls ages 13 through 17 in Rhode Island, New Hampshire and Massachusetts got at least one dose of the three-shot vaccination. Mississippi, Georgia and South Carolina -- with fewer than 20 percent who got at least one shot -- were among the stated with the lowest rates...

2009-09-14 01:01:51

U.S. officials say they're considering approving male use of the HPV vaccine that females have been taking since 2006. The Food and Drug Administration advisory committee has recommended males 9 to 26 get Gardasil, a vaccine against the human papillomavirus, a sexually transmitted disease that can cause genital warts and cervical cancer, the Salt Lake Tribune reported. The FDA is expected to decide on the recommendation by year's end. The vaccine was first used for girls and young women in...